- Home
- OPK
OPK
OPKO Health Inc.
as 11-21-2024 4:00pm EST
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | MIAMI |
| Market Cap: | 1.1B | IPO Year: | 1995 |
| Target Price: | $2.75 | AVG Volume (30 days): | 4.8M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.19 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.85 - $1.75 | Next Earning Date: | 11-07-2024 |
| Revenue: | $711,408,000 | Revenue Growth: | -17.94% |
| Revenue Growth (this year): | -17.89% | Revenue Growth (next year): | 0.50% |
Stock Insider Trading Activity of OPKO Health Inc. (OPK)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Nov 8 '24 | Buy | $1.50 | 280,183 | $421,535.32 | 211,512,405 |
Latest OPKO Health Inc. News
OPK Breaking Stock News: Dive into OPK Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference
PR Newswire
4 days ago
NextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition Expo
Barrons.com
6 days ago
Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors
PR Newswire
8 days ago
NextPlat Reports $49.8 Million in Consolidated Revenue for the Nine Months Ended September 30, 2024, Representing a 136% Increase Over 2023 Results
Simply Wall St.
11 days ago
Phillip Frost Buys Handful Of Shares In OPKO Health
Simply Wall St.
13 days ago
OPKO Health Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
MT Newswires
13 days ago
Opko Health Insider Bought Shares Worth $421,535, According to a Recent SEC Filing
GlobeNewswire
13 days ago
Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates
Compare OPK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OPK OPKO Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.